Approval · Notice of Compliance 27978 · 2022
EVUSHELD: Notice of Compliance 27978
Issued April 14, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27978
- Date
- April 14, 2022
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVUSHELD | 02526271 | Cancelled Post Market |
Medicinal ingredients
- TIXAGEVIMAB 150 MG per 1.5ML
- CILGAVIMAB 150 MG per 1.5ML